Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Bodei

Showing results (41-50 of 184) with videos related to

Pageof 19
Sort By:
Clinical Nuclear Medicine|October 30, 2018
Enchondroma of Tibia as Potential False-positive Finding on 68Ga-DOTATOC PET/CT ScanSonia Mahajan, Lisa Bodei, Sandra Huicochea Castellanos, et al.
Neuroendocrinology|November 7, 2019
The Use of Deep Learning and Neural Networks in Imaging: Welcome to the New Mathematical Milieu of MedicineIrvin M Modlin, Mark Kidd, Ignat A Drozdov, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 19, 2004
Radionuclide therapy with iodine-125 and other auger-electron-emitting radionuclides: experimental models and clinical applicationsLisa Bodei, Amin I Kassis, S James Adelstein, et al.
Journal of Thoracic Disease|December 5, 2017
The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumorsLisa Bodei, Jarosław B Ćwikla, Mark Kidd, et al.
Nature Reviews. Drug Discovery|July 31, 2020
Radiopharmaceutical therapy in cancer: clinical advances and challengesGeorge Sgouros, Lisa Bodei, Michael R McDevitt, et al.
Endocrine Connections|October 16, 2014
A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitorsIrvin M Modlin, Harry Aslanian, Lisa Bodei, et al.
Cancer Journal (Sudbury, Mass.)|May 16, 2024
Radiopharmaceuticals for Cancer Diagnosis and Therapy: New Targets, New Therapies-Alpha-Emitters, Novel TargetsNeil K Taunk, Freddy E Escorcia, Jason S Lewis, et al.
Neuroendocrinology|September 18, 2014
The status of neuroendocrine tumor imaging: from darkness to light?Lisa Bodei, Anders Sundin, Mark Kidd, et al.
PET Clinics|April 8, 2025
Neuroendocrine Tumors: Beta Labeled RadiopeptidesLisa Bodei, Vetri Sudar Jayaprakasam, Bernadette Zhi Ying Wong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2019
The Path to the Future: Education of Nuclear Medicine Therapeutic Specialists as Responsible PhysiciansLisa Bodei, Arturo Chiti, Irvin M Modlin, et al.
Pageof 19

Showing results (41-50 of 184) with videos related to

Sort By:
Pageof 19
Clinical Nuclear Medicine|October 30, 2018
Enchondroma of Tibia as Potential False-positive Finding on 68Ga-DOTATOC PET/CT ScanSonia Mahajan, Lisa Bodei, Sandra Huicochea Castellanos, et al.
Neuroendocrinology|November 7, 2019
The Use of Deep Learning and Neural Networks in Imaging: Welcome to the New Mathematical Milieu of MedicineIrvin M Modlin, Mark Kidd, Ignat A Drozdov, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 19, 2004
Radionuclide therapy with iodine-125 and other auger-electron-emitting radionuclides: experimental models and clinical applicationsLisa Bodei, Amin I Kassis, S James Adelstein, et al.
Journal of Thoracic Disease|December 5, 2017
The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumorsLisa Bodei, Jarosław B Ćwikla, Mark Kidd, et al.
Nature Reviews. Drug Discovery|July 31, 2020
Radiopharmaceutical therapy in cancer: clinical advances and challengesGeorge Sgouros, Lisa Bodei, Michael R McDevitt, et al.
Endocrine Connections|October 16, 2014
A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitorsIrvin M Modlin, Harry Aslanian, Lisa Bodei, et al.
Cancer Journal (Sudbury, Mass.)|May 16, 2024
Radiopharmaceuticals for Cancer Diagnosis and Therapy: New Targets, New Therapies-Alpha-Emitters, Novel TargetsNeil K Taunk, Freddy E Escorcia, Jason S Lewis, et al.
Neuroendocrinology|September 18, 2014
The status of neuroendocrine tumor imaging: from darkness to light?Lisa Bodei, Anders Sundin, Mark Kidd, et al.
PET Clinics|April 8, 2025
Neuroendocrine Tumors: Beta Labeled RadiopeptidesLisa Bodei, Vetri Sudar Jayaprakasam, Bernadette Zhi Ying Wong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2019
The Path to the Future: Education of Nuclear Medicine Therapeutic Specialists as Responsible PhysiciansLisa Bodei, Arturo Chiti, Irvin M Modlin, et al.
Pageof 19